Agnete Fredriksen, Ph.D.

Agnete Fredriksen, Ph.D.Member of the Board of Directors

Agnete Fredriksen, Ph.D., is a co-founder and Chief Business Officer of Nykode Therapeutics AS (formerly Vaccibody AS), a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel immunotherapies for cancer and infectious diseases. She has served in various roles including Chief Scientific Officer from 2007-2022. Prior to founding Vaccibody, Dr. Fredriksen previously held research roles at Affitech AS, a private technology transfer company, and Medinnova AS, a technology transfer company. She is the author of numerous scientific papers in the field of immunology, immunotherapy and vaccines, and has been awarded several patents in the field of immunotherapy. She holds an MSc and a Ph.D. from the Institute of Immunology, Rikshospitalet Medical Center in Oslo, Norway.